Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Novartis files for U.S., European approval of new IBS treatment

Feb. 17, 2000

Patient dosing begins in phase I study of first anti-HCV ribozyme therapy

Feb. 17, 2000

Vion licenses potential HBV/HIV therapy to Achillion

Feb. 14, 2000

FDA to review Schering-Plough's BLA for PEG-Intron

Feb. 11, 2000

FDA approves Lotronex for IBS in women

Feb. 10, 2000

AxyS enters drug design agreement with Bristol-Myers Squibb

Feb. 9, 2000

Gastric antisecretory agents from KRICT superior to omeprazole in vitro and in vivo

Feb. 8, 2000

FDA approves tablet formulation of Protonix for erosive esophagitis

Feb. 7, 2000

New oral IBD treatment targets macrophages and microfold cells

Feb. 1, 2000

SciClone initiates phase II study of Zadaxin in hepatitis B

Jan. 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...